Skip to content

Clinical Characterization of an Investigational Soft Silicone Hydrogel Contact Lens

Clinical Characterization of an Investigational Soft Silicone Hydrogel Contact Lens

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04631796
Enrollment
36
Registered
2020-11-17
Start date
2020-12-03
Completion date
2020-12-31
Last updated
2022-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Errors

Keywords

Vision, Contact lenses

Brief summary

The primary objective of this study is to evaluate the overall clinical performance of an investigational silicone hydrogel contact lens over 2 weeks of daily wear.

Detailed description

Participants will attend a Screening visit, a Dispense visit (0 to 4 days later), and a follow-up visit approximately 2 weeks after the Dispense visit.

Interventions

Silicone hydrogel contact lenses with investigational coating

DEVICEMultipurpose disinfection solution

Solution for cleaning, disinfecting, and reconditioning silicone hydrogel contact lenses

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Understand and sign an Informed Consent that has been approved by an Institutional Review Board. * Successful wear of spherical weekly/monthly soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months. * Willing to stop wearing habitual contact lenses for the duration of study participation. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Any condition that contraindicates contact lens wear, as determined by the Investigator. * Any use of systemic or ocular medications that contraindicates contact lens wear, as determined by the Investigator. * History of refractive surgery or plan to have refractive surgery during the study. * Current or history of dry eye in either eye that, in the opinion of the Investigator, would preclude contact lens wear. * Habitual contact lenses worn in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment. * Any use of topical ocular medications or artificial tear or rewetting drops that would require instillation during contact lens wear. * Monovision or multifocal contact lens wear. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Front Surface Wettability, by CategoryDispense; Week 2 Follow-upFront surface wettability (i.e., assessment of the disruption of the front surface wettability of the contact lens) was assessed by the investigator for each eye individually. Front surface wettability was collected on a 5-point scale, where where Grade 0 = a smooth uniformly reflecting surface and Grade 4 = non-wettable lens surface. No formal hypothesis was predefined for the primary endpoint. No inferential testing was performed.

Countries

United States

Participant flow

Recruitment details

Subjects were recruited from 3 investigative sites located in the United States.

Pre-assignment details

Of the 36 enrolled, 1 subject was exited from the study prior to product exposure as a screen failure. This reporting group includes all subjects/eyes exposed to any study lenses evaluated in this study, except for the lenses used with the purpose of power optimization (Safety Analysis Set).

Participants by arm

ArmCount
LID020098
Lehfilcon A contact lenses worn in both eyes for 2 weeks. Lenses were removed nightly for cleaning and disinfection.
35
Total35

Baseline characteristics

CharacteristicLID020098
Age, Continuous34.4 years
STANDARD_DEVIATION 9
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
31 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
34 Participants
Region of Enrollment
United States
35 participants
Sex: Female, Male
Female
21 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 350 / 700 / 35
other
Total, other adverse events
0 / 350 / 702 / 35
serious
Total, serious adverse events
0 / 350 / 700 / 35

Outcome results

Primary

Front Surface Wettability, by Category

Front surface wettability (i.e., assessment of the disruption of the front surface wettability of the contact lens) was assessed by the investigator for each eye individually. Front surface wettability was collected on a 5-point scale, where where Grade 0 = a smooth uniformly reflecting surface and Grade 4 = non-wettable lens surface. No formal hypothesis was predefined for the primary endpoint. No inferential testing was performed.

Time frame: Dispense; Week 2 Follow-up

Population: Safety Analysis Set

ArmMeasureGroupValue (NUMBER)
LID020098Front Surface Wettability, by CategoryDispense, Grade 070 eyes
LID020098Front Surface Wettability, by CategoryDispense, Grade 10 eyes
LID020098Front Surface Wettability, by CategoryDispense, Grade 20 eyes
LID020098Front Surface Wettability, by CategoryDispense, Grade 30 eyes
LID020098Front Surface Wettability, by CategoryDispense, Grade 40 eyes
LID020098Front Surface Wettability, by CategoryWeek 2 Follow-up, Grade 070 eyes
LID020098Front Surface Wettability, by CategoryWeek 2 Follow-up, Grade 10 eyes
LID020098Front Surface Wettability, by CategoryWeek 2 Follow-up, Grade 20 eyes
LID020098Front Surface Wettability, by CategoryWeek 2 Follow-up, Grade 30 eyes
LID020098Front Surface Wettability, by CategoryWeek 2 Follow-up, Grade 40 eyes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026